CABOT WEALTH MANAGEMENT INC Q4 2018 Filing

Filed February 12, 2019

Portfolio Value

$409.6M

Holdings

128

Report Date

Q4 2018

Filing Type

13F-HR

All Holdings (128 positions)

#StockSharesValue% PortfolioType
101
DowDupont Inc
6,032$323K0.08%
102
VTIVanguard Index Fds
2,532$323K0.08%
103
NDQInvesco QQQ Tr
2,085$322K0.08%
104
BSCKInvesco Exch Trd Slf Idx Fd
14,964$315K0.08%
105
GDGeneral Dynamics Corp
1,999$314K0.08%
106
PAYXPaychex Inc
4,824$314K0.08%
107
KOCoca Cola Co
6,346$300K0.07%
108
PFEPfizer Inc
6,829$298K0.07%
109
SYSBIshares Tr
3,049$292K0.07%
110
VEAVanguard Tax Managed Intl Fd
7,622$283K0.07%
111
AQLTIshares Tr
3,105$277K0.07%
112
SHMSPDR SER Tr
5,571$268K0.07%
113
WYWeyerhaeuser Co
11,998$262K0.06%
114
VPUVanguard World Fds
2,203$260K0.06%
115
MRKMerck & Co Inc.
3,200$245K0.06%
116
ABTAbbot Labs
3,321$240K0.06%
117
WFCWells Fargo Co New
5,182$239K0.06%
118
MUNIPimco ETF Tr
4,494$237K0.06%
119
LLYLilly Eli & Co
2,000$231K0.06%
120
FMUSDIshares Inc
8,825$231K0.06%
121
IWMIshares Tr
1,721$230K0.06%
122
PEGPublic Svc Enterprise Group
4,346$226K0.06%
123
REZIshares Tr
3,508$219K0.05%
124
PSXPhillips 66
2,374$205K0.05%
125
BSCMUSDInvesco Exch Trd Slf Idx Fd
9,940$205K0.05%
126
WBAWalgreens Boots Alliance Inc
2,970$203K0.05%
127
GEGeneral Electric Co
11,964$91K0.02%
128
Navidea Biopharmaceuticals I
61,496$6K0.00%
PreviousPage 2 of 2